Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
26 July 2013
Header
Header image
News

News

EFPIA and PhRMA Release Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients
24 July 2013

Data Sharing Commitments will Enhance Research and Scientific Knowledge, Advance Patient Care and Improve Public Health Read more

From our blog

From our blog

EFPIA PhRMA Joint Commitment to Data Sharing: Enhancing Science for Patient Benefit
24 July 2013 by Richard Bergström

Sharing different opinions and open debate are necessary for progress. I have reiterated this point many times in my calls for collaboration between the pharmaceutical [...] Read more

Videos

Video

Watch Out for False Friends

Every day, fake medicines find their way into online and physical pharmacies, hospitals, and street markets. This plague knows no borders. In the best case scenario, fake medicines leave patients with no side-effects but also without a cure. In many other cases, however, they can kill people. We have to get smarter than the criminals to put a stop to this silent public health threat.

View video

Documents

The Pharmaceutical Industry in figures - Edition 2013
19 June 2013 (Publications)

Main Trends The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and ensuring future competitiveness in an advancing global economy. In [...] Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail